Discuss This Drug

dexlansoprazole

CHEBI:CHEBI_135931

Chemical Information

Molecular Formula: C16H14F3N3O2S
Molecular Mass: 369.363
Charge: 0
SMILES: CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C2=NC3=C(N2)C=CC=C3
InChI: InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1
InChIKey: MJIHNNLFOKEZEW-RUZDIDTESA-N

Alternative Names

(R)-Lansoprazole
dexilant
dexlansoprazole sesquihydrate
kapidex
R-Lansoprazole
TAK-390
TAK-390MR

Treatment Applications

megaesophagus
DOID:13186

View Disease →
esophageal basaloid squamous cell carcinoma
DOID:7051

View Disease →
obsolete recurrent squamous cell carcinoma of the esophagus
DOID:7543

View Disease →
esophagus squamous cell papilloma
DOID:959

View Disease →

Drug Classification

sulfoxide
CHEBI:22063

View Class →
benzimidazoles
CHEBI:22715

View Class →

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

Always consult with a healthcare professional before starting, stopping, or modifying any medication.
Side effects may vary and this list may not be comprehensive.
Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000: 816346
oboInOwl#hasDbXref: Drug_Central:4162
core#notation: CHEBI:135931

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

has_treatment: http://purl.obolibrary.org/obo/DOID_9206
owl#someValuesFrom: t2997675
oboInOwl#hasOBONamespace: chebi_ontology
DRON_00010000: 816346
oboInOwl#hasDbXref: Drug_Central:4162
oboInOwl#id: CHEBI:135931
generic_name: Dexlansoprazole Sesquihydrate
product_type: BULK INGREDIENT
marketing_category: BULK INGREDIENT
dosage_form: CAPSULE, DELAYED RELEASE
labeler_name: TWI PHARMACEUTICALS, INC.
brand_name: Dexilant
brand_name_base: Dexilant
product_ndc: 49711-1513
application_number: NDA022287
oboInOwl#inSubset: http://purl.obolibrary.org/obo/chebi#2_STAR
listing_expiration_date: 20241231
route: ORAL
marketing_start_date: 20090312
spl_id: be743bff-926e-436d-b67c-c9f6e10ea2ea
package_ndc: 49711-1513-0
rxcui: 902626
package_marketing_start_date: 04-MAR-14
manufacturer_name: TWI PHARMACEUTICALS, INC.
package_description: 25 kg in 1 DRUM (49711-1513-0)
core#notation: CHEBI:135931
active_ingredient_strength: 10 kg/10kg
nui: N0000000147
pharm_class_epc: Proton Pump Inhibitor [EPC]
pharm_class: Proton Pump Inhibitors [MoA]
pharm_class_moa: Proton Pump Inhibitors [MoA]
active_ingredient_name: DEXLANSOPRAZOLE
unii: HS2S9VK3NH
spl_set_id: 3ed69e5a-aa78-4118-aa32-59a10f80c901
brand_name_suffix: delayed release
upc: 0324979002064
22-rdf-syntax-ns#type: http://www.w3.org/2002/07/owl#Class
rdf-schema#range: https://w3id.org/def/predibionto#has_drug_113735
rdf-schema#domain: https://w3id.org/def/predibionto#has_side_effect4836
owl#annotatedSource: t108795